The global cerebral spinal fluid management market is expected to witness moderate growth in the coming years.
The growth is predicted to be at a CAGR of 5.3% between 2021 to 2028, the market is expected to reach the valuation of USD 2.61bn by the end of 2028.
Researchmoz throws some light on the global cerebral spinal fluid management market including market size, drivers, restraints, trends, opportunities, market segmentation, and competitive landscape.
Lately, there has been a rise in the number of brain surgeries, globally, the increase in such surgeries is paving the way for the expansion of the global cerebral spinal fluid management market.
With the onset of the covid-19 pandemic, the market went through a dull period as surgeries had to be delayed and covid treatment was put on high priority.
As the world is regaining its grip on the economies, the global cerebral spinal fluid market is finding its place back in the medical sector.
Factors Driving and Restraining the Market
Some of the determinants that drive the global cerebral spinal fluid management market are-
- Increasing cases of meningitis are anticipated to boost the market for cerebral spinal fluid, owing to its use in the diagnosis of meningitis.
- The growing geriatric population and neurovascular disorders associated with old age are projected to expand cerebral spinal fluid management during the forecast period.
- Increasing cases of congenital hydrocephalus among babies are expected to amplify growth in the global cerebral spinal fluid management market in the next few years.
- The rising cases of brain tumours across the globe are expected to drive the demand for cerebral spinal fluid management.
- The increasing investments in research and development in the area of cerebral spinal fluid management is likely to push the growth in the market.
- The grants especially for research in neuromodulation therapies and cure is anticipated to stimulate the expansion of the cerebral spinal fluid management market.
There are certain challenges in the global cerebral spinal fluid management market which may act as restraints during the forecast period.
- The lack of trained professionals to handle cerebral spinal fluid devices may hinder the growth of the market.
- Further, the fear of side effects and the high cost of such surgeries is expected to hamper the expansion of the cerebral spinal fluid management market in the forecast period.
However, the increasing cases of rhinosinusitis with nasal polyps is expected to navigate the cerebral spinal fluid management market to swell up in the near future.
- The global cerebral spinal fluid management market is predicted to grow steadily, registering a growth a CAGR of 5.3% during the forecast period 2021 to 2028.
- The innovation and technology to stimulate the market expansion in the coming years.
- Novel molecular and cellular biology insights are challenging the traditional concepts of cerebral spinal fluid, thus leading to amplification of the global cerebral spinal fluid management market during the forecast period.
- Antinuclear antibodies in the geriatric population could lead to intensified demand for cerebral spinal fluid in the coming years.
- The market is evolving back from the negative impacts of covid and is set to thrive back in the medical sector.
- The shunt segment is expected to witness high sales in the global cerebral spinal fluid management market, owing to its ability to take out excess fluid from the brain and pass it on to the abdomen, so that it gets absorbed in the abdomen.
- Further, due to rising cases of congenital hydrocephalus in infants, the paediatric segment is expected to bolster the demand for cerebral spinal fluid management during the forecast years.
- The major share in the market is likely to be held by the Asia Pacific, owing to the rising population, growing geriatric population, better healthcare infrastructure, and increasing medical tourism.
The major players in the global cerebral spinal fluid management are-
- Integra Life Sciences
- BeckerSmith Medical
- DePuy Synthes Companies (Johnson & Johnson)
- BeckerSmith Medical
Product Disposition (Revenue in USD million)
- CSF Shunts
- Adjustable CSF Shunts
- Fixed CSF Shunts
- CSF Drainage Systems
- Lumbar Drainage System
- Ventricular Drainage System
Application Disposition (Revenue in USD million)
End-User Disposition (Revenue in USD million)
- Ambulatory Surgical Centres
- Neurological Centres
Table of Content
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Cerebral Spinal Fluid (CSF) Management Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
Download Report PDF: Cerebral Spinal Fluid (CSF) Management Market